Location History:
- Neckargemund, DE (2021)
- Neckargemünd, DE (2023)
Company Filing History:
1 out of 1 
1 out of 30 
1 out of 4 Years Active: 2021-2023
Title: Christian Kleist: Innovator in Immunosuppressive Therapies
Introduction
Christian Kleist is a notable inventor based in Neckargemund, Germany. He has made significant contributions to the field of immunosuppression, particularly in transplantation and autoimmune diseases. With a total of two patents to his name, Kleist's work is paving the way for advancements in medical treatments.
Latest Patents
Kleist's latest patents include "MIC therapy for specific immunosuppression in transplantation." This invention relates to pharmaceutical compositions that utilize isolated and treated whole blood cells or Peripheral Blood Mononuclear Cells (PBMCs). These compositions are designed for the prevention and treatment of organ or cell graft rejection in human graft recipients. Another significant patent is "Immunosuppressive blood cells and methods of producing the same." This invention outlines a method for producing immunosuppressive blood cells that can be utilized in treating autoimmune diseases, including multiple sclerosis, organ graft rejection, and graft-versus-host disease.
Career Highlights
Throughout his career, Christian Kleist has worked with prominent organizations such as Tolerogenixx GmbH and Universität Heidelberg. His experience in these institutions has allowed him to develop innovative solutions in the medical field.
Collaborations
Kleist has collaborated with esteemed colleagues, including Gerhard Opelz and Peter Terness. Their combined expertise has contributed to the advancement of immunosuppressive therapies.
Conclusion
Christian Kleist's contributions to immunosuppressive therapies through his patents and collaborations highlight his role as an influential inventor in the medical field. His work continues to impact the treatment of organ graft rejection and autoimmune diseases.